Advisory Boards

Scientific Advisory Board

Vanessa Gabrovsky Cuellar, MD

Scientific Advisory Board

Dr. Vanessa G. Cuellar graduated from the Honors Program in Microbiology, Immunology and Molecular Genetics at the University of California, Los Angeles (UCLA), completing an honors thesis in the laboratory of Jeffrey H. Miller in DNA repair and mutagenesis. She was awarded a Medical Scholars research fellowship in medical school and studied non-viral gene therapy in the lab of Michele P. Calos in the Department of Genetics at Stanford University School of Medicine. Her affiliation with Cytonics follows early research collaborations with Dr. Gaetano Scuderi leading to the identification of molecular biomarkers of painful arthropathy. She is currently a resident in orthopaedic surgery at NYU Hospital for Joint Diseases as part of the Clinician Scientist Training Program, and has completed a year of research in molecular biomarkers of osteoarthritis and cartilage disease in the Musculoskeletal Research Center at NYU.

Jason M. Cuellar, MD PhD

Scientific Advisory Board

Dr. Cuellar graduated from U.C. Davis with a degree in Neurobiology, Physiology and Behavior. He then pursued his doctorate under Earl Carstens in Molecular, Cellular and Integrative Physiology at U.C. Davis, concluding in a dissertation on the molecular mechanisms of pain. He attended Stanford University School of Medicine and completed post-doctoral training in the lab of D. C. Yeomans. He is currently training in orthopaedic surgery at NYU Hospital for Joint Diseases, as a fellow in the clinician scientist training program.

David C. Yeomans, PhD

Scientific Advisory Board

Dr. Yeomans is a Professor in the Department of Anesthesia at Stanford Medical School. He is also Director of Pain Research and of the Medical Neuroscientist Program at Stanford. He received his bachelor’s degree in Psychology from Dartmouth College in Hanover, New Hampshire, and his PhD in Neuroscience from the University of Florida, where he studied the differential effects of strong narcotic analgesics on different types of pain. His current academic interests focus primarily on gene therapy for chronic pain and biomarkers for different pain types.

Medical Advisory Board

Wayne Olan, MD

Medical Advisory Board

Dr. Olan is board-certified in Radiology, the director of Invasive and Endovascular Neurosurgery, and an associate professor at The George Washington University Medical Center. He is also a consulting physician to the National Institutes of Health. He completed his training in Radiology and fellowship training in Neuroradiology with subspecialty training in Interventional Neuroradiology. Dr. Olan has published extensively on minimally invasive spinal interventions, endovascular treatments, and cervical abnormalities. He lectures on minimally invasive spinal techniques and is involved in the development of many devices in the spinal arena. He has also published and lectured on cerebrovascular abnormalities, especially revascularization, and stroke prevention and treatment.

Thomas San Giovanni, MD

Medical Advisory Board

Dr. Thomas San Giovanni is a Board-certified orthopedic surgeon at Doctors Hospital in Coral Gables, Florida, specializing in conditions of the foot and ankle. He received his medical degree from George Washington University School of Medicine in Washington, D.C. He subsequently completed an orthopedic surgical residency at the University of Miami and two fellowships at Harvard Medical School in Foot and Ankle surgery and Pediatric Orthopedic Surgery. He also completed a Robert Wood Johnson Research Fellowship at Columbia University’s College of Physicians and Surgeons in New York City. Dr. San Giovanni is the orthopedic surgeon for the Miami City Ballet. He also serves as a foot and ankle surgical consultant to the Florida Panthers, Tampa Bay Buccaneers, Florida International University and Miami-Dade County Public Schools.

Martin Angst, MD

Medical Advisory Board

Dr. Martin Angst holds an appointment as a Professor of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine. His research focuses on studying immune health in the context of surgery and trauma to identify molecular immune trajectories that are highly predictive of aversive trauma-associated outcomes including protracted recovery and infection. Dr. Angst has been sponsored by the National Institute of Health, the Defense Advanced Research Projects Agency, private foundations and the pharmaceutical industry. He has published over 70 peer-reviewed articles, has authored several book chapters and serves on the editorial board of peer-reviewed journals in the field of anesthesia and pain medicine. Dr. Angst has been an expert consultant to the biotechnical, pharmaceutical, and legal industry. He received his MD degree from the University of Berne, Switzerland, in 1993 and completed his fellowship training in clinical pharmacology in 1996 at the Department of Anesthesiology, Perioperative and Pain Medicine of Stanford University Medical School.

Joseph Buckwalter, MD

Medical Advisory Board

Dr. Buckwalter has been conducting basic, translational and clinical research directed toward advancing understanding of the role of joint injury in causing osteoarthritis for more than three decades. He is Professor and former Chairman of the Department of Orthopaedics and Rehabilitation at the University of Iowa. Dr. Buckwalter has served as the President of the Orthopaedic Research Society; the Co-Editor, Journal of Orthopaedic Research; the President, American Board of Orthopaedic Surgery; and the President, American Orthopaedic Association, as well as in a significant number of other positions. He has multiple grants funded by the National Institute of Health, the Department of Defense and Veterans Administration and private foundations. He has published over 400 peer-reviewed articles, has authored more than 100 book chapters and serves on the editorial board of peer-reviewed journals in the field of orthopedic medicine.

Dr. Buckwalter is a board-certified orthopedic surgeon with clinical and research interests in osteoarthritis, musculoskeletal oncology, sports medicine and trauma. He earned his BS and MA degrees from the University and his medical degree from the University of Iowa, Carver College of Medicine, in Iowa City, IA. He completed an orthopedic surgical residency at the University of Iowa, and was a National Resident Service Award Fellow at the University of Iowa Hospitals and Clinics in Iowa City, IA. Dr. Buckwalter is a member of the American Academy of of Orthopedic Surgeons, the Orthopedic Research Society, the Royal College of Surgeons (Ed), the Institute of Medicine National Academy of Sciences and numerous other professional and scientific societies.

Dr. Geoff Abrams, MD

Medical Advisory Board

Dr. Abrams specializes in Sports Medicine and arthroscopy, upper extremity joint replacement, as well as ligament reconstructive surgery of the shoulder, knee, hip and elbow. He is a member of the American Academy of Orthopedic Surgeons (AAOS), American Orthopedic Society for Sports Medicine (AOSSM), and the Arthroscopy Association of North America (AANA), among others. He is actively involved in cartilage restoration research, particularly for the shoulder and upper extremity, in addition to the role of inflammatory mediators on cartilage destruction and rotator cuff pathology. Dr. Abrams received his undergraduate degree from Stanford University and his Doctor of Medicine from the University of California – San Diego. He completed his residency in Orthopedic Surgery at Stanford University and went on to receive addition training in Orthopedic Sports Medicine and Shoulder Surgery at Rush University Medical Center in Chicago, Illinois. He has participated in caring for the Chicago Bulls basketball team and Chicago Whitesox baseball team and currently serves as Team Physician for a number of varsity sports at Stanford University as well as Notre Dame de Namur University. Dr. Abrams has authored or co-authored over 40 peer-reviewed scientific articles, over 20 book chapters, has presented original research at numerous national and international scientific meetings, and serves as a reviewer for numerous Sports Medicine scientific journals.

Board of Directors

Jeff White

Board of Directors

Mr. White has operated in the surgical device, biomaterials and biologics industry for 35 years as a senior marketing, business development and chief executive in Fortune 500, mid-size and start-up firms. He is currently Vice President, Product Management at MiMedx Group, Inc., the leading provider of placental tissue allografts. He is Founder and Principal, Medtech Advisory Group LLC and previously served as Global Director of Business Development for Synthes, a $4 billion global orthopedic firm that was acquired by Johnson and Johnson in 2012. He is a member of the AOSpine and ISASS spine societies and serves on the board of Amedica Corporation (NASDAQ, AMDA), a developer of specialty orthopedic ceramics.
Previously he was founder or President/CEO and board member of start-up device firms EnSurg, Surgicon, Applied Spine Technologies and Liventa Bioscience. Prior to his start-up career Mr. White was Senior Director of Marketing and Business Development at US Surgical Corporation which was the global leader in surgical stapling and laparoscopy devices and is now a part of Covidien/Medtronic Minimally Invasive Technologies.

Gaetano Scuderi, MD

Board of Directors

Dr. Scuderi is the founder of Cytonics Corporation. Dr. Scuderi is a fellowship-trained spine surgeon and has practiced medicine since 1993. He is currently a Clinical Assistant Professor in the Department of Orthopedic Surgery of Stanford University. He graduated medical school from State University of New York at Buffalo, N.Y. and completed his Residency and Internship at University of Miami School of Medicine. Dr. Scuderi has published over 35 scientific articles and is a member of American Academy of Orthopaedic Surgeons and the North American Spine Society.

Ivan Bargueiras

Board of Directors

Mr. Bargueiras is senior vice president of advertising sales for the 15 networks that are part of Discovery Networks Latin America/US Hispanic (DLA/USH). He is responsible for overseeing TV and online advertising sales activities for all DLA/USH networks throughout the region and international markets. In addition, he leads Discovery’s international sales group which targets US-based clients interested in global campaigns. He was also named General Manager for Discovery US Hispanic. Bargueiras previously served as vice president and group director of advertising sales for Discovery Networks Latin America/Iberia. Prior to joining Discovery, Bargueiras served as advertising manager for the Weather Channel and Travel Channel, where he structured the sales departments and developed sales strategies for the networks’ Latin American operations.